{
  "id": "resp_0c12466038642fbe00693c89d115d4819095caa2deebf0f576",
  "object": "response",
  "created_at": 1765575121,
  "status": "completed",
  "background": false,
  "billing": {
    "payer": "developer"
  },
  "error": null,
  "incomplete_details": null,
  "instructions": null,
  "max_output_tokens": null,
  "max_tool_calls": null,
  "model": "gpt-5.2-2025-12-11",
  "output": [
    {
      "id": "rs_0c12466038642fbe00693c89d17370819084ff486d1d0d1c42",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_0c12466038642fbe00693c89d5a108819099da6423f89c3601",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "PgR drug code"
      }
    },
    {
      "id": "rs_0c12466038642fbe00693c89d7d7788190938f0b608d2a49df",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_0c12466038642fbe00693c89e23b7c81908da4d741eebd7456",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "\"PgR\" compound"
      }
    },
    {
      "id": "rs_0c12466038642fbe00693c89e466908190bb33e0befb8b9db3",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_0c12466038642fbe00693c89fa5e5481908211bc198344f967",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "\"PgR\" \"phase\" trial drug"
      }
    },
    {
      "id": "rs_0c12466038642fbe00693c89fc6dac8190b6bf81c0d94caa9b",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "msg_0c12466038642fbe00693c8a09aaa08190addfd9a6b5daf416",
      "type": "message",
      "status": "completed",
      "content": [
        {
          "type": "output_text",
          "annotations": [],
          "logprobs": [],
          "text": "{\n  \"validated\": false,\n  \"assets\": [],\n  \"rejected_reason\": \"Candidate identifier \\\"PgR\\\" refers to the progesterone receptor (PGR/PR), used as a breast cancer biomarker/hormone receptor status (e.g., PgR-positive), not a specific drug asset; thus sponsor/target/modality/indication/stage/geography for a drug cannot be validated. Evidence: https://www.cancer.gov/types/breast/diagnosis/breast-cancer-biomarker-tests ; https://bmccancer.biomedcentral.com/articles/10.1186/s12885-017-3331-4\"\n}"
        }
      ],
      "role": "assistant"
    }
  ],
  "parallel_tool_calls": true,
  "previous_response_id": null,
  "prompt_cache_key": null,
  "prompt_cache_retention": null,
  "reasoning": {
    "effort": "xhigh",
    "summary": null
  },
  "safety_identifier": null,
  "service_tier": "default",
  "store": true,
  "temperature": 1.0,
  "text": {
    "format": {
      "type": "text"
    },
    "verbosity": "medium"
  },
  "tool_choice": "auto",
  "tools": [
    {
      "type": "web_search",
      "filters": null,
      "search_context_size": "medium",
      "user_location": {
        "type": "approximate",
        "city": null,
        "country": "US",
        "region": null,
        "timezone": null
      }
    }
  ],
  "top_logprobs": 0,
  "top_p": 0.98,
  "truncation": "disabled",
  "usage": {
    "input_tokens": 18503,
    "input_tokens_details": {
      "cached_tokens": 4736
    },
    "output_tokens": 2921,
    "output_tokens_details": {
      "reasoning_tokens": 2780
    },
    "total_tokens": 21424
  },
  "user": null,
  "metadata": {}
}